Chapter_019-Ht Fail-Dysrr-4th PPT
Chapter 19: Heart Failure and Dysrhythmias
Overview of Heart Failure
Definition: Inability of the heart to maintain sufficient cardiac output to meet the metabolic demands of tissues and organs.
Consequences: Results in congestion in systemic or pulmonary circulation and inability to increase cardiac output with increased demand.
Statistics: Increasing incidence with more common hospitalization in individuals over 65; five-year survival rate is about 50% even with treatment.
Etiology and Pathogenesis
Common Causes:
Myocardial ischemia.
Hypertension.
Dilated cardiomyopathy.
Mechanism: Impaired myocardial fiber contraction, relaxation, or both.
Types of Dysfunction
Systolic Dysfunction
Description: Impaired contractility leading to a low ejection fraction.
Characteristics:
Evidenced by reduced inotropy during ventricular systole.
Loss of cardiac muscle cells and reduced ATP production.
Diastolic Dysfunction
Causes: Associated with ischemic heart disease and hypertension.
Affected Populations: Elderly, women, and those without a history of myocardial infarction.
Characteristics:
Noncompliant ventricle failing to fill effectively.
Low cardiac output, edema formation, normal ejection fraction.
Compensatory Mechanisms and Remodeling
Importance: Helpful in restoring cardiac output toward normal but detrimental long-term.
Responses:
SNS activation.
Increased preload.
Myocardial hypertrophy.
Note: Cardiac muscle can regenerate if stem cells are present.
Sympathetic Nervous System Activation
Trigger: Baroreceptor reflex due to pressure drop.
Responses:
Increased CNS activity leading to venoconstriction, increasing venous return and cardiac output.
Renin release from juxtaglomerular cells, activating RAAS, resulting in sodium and water retention.
Increased Preload
Mechanism:
Reduced ejection fraction leads to elevated residual end-systolic volume (ESV).
Decreased cardiac output to the kidney reduces glomerular filtration.
RAAS activation increases blood volume.
Frank-Starling Mechanism: Changes in preload affect muscle contraction efficiency.
Myocardial Hypertrophy and Remodeling
Cause: Chronic elevation of myocardial wall tension.
Consequences: High systolic pressure required to overcome afterload leading to hypertrophy.
Involvement: Neurohormonal factors like angiotensin II contribute to remodeling.
Clinical Manifestations
Left Ventricular Failure: Most common type; can lead to right ventricular failure.
Forward Effects: Insufficient pumping leads to poor cardiac output.
Backward Effects: Congestion of blood behind the pumping chamber.
Left-Sided Heart Failure
Backward Effects: Pulmonary circulation congestion, edema, and diminished oxygen delivery.
Forward Effects: Insufficient cardiac output impacting tissues and organs.
Right-Sided Heart Failure
Mechanism: Often from pulmonary disorders increasing vascular resistance leading to right ventricular failure.
Backward Effects: Congestion in systemic venous system.
Forward Effects: Low output to left ventricle causing low cardiac output.
Biventricular Heart Failure
Cause: Primary left-sided failure progressing to right-sided failure.
Symptoms: Reduced cardiac output, pulmonary congestion, and systemic venous congestion.
Class and Stage of Heart Failure
Assessment: FACES criteria (fatigue, activity limitation, congestion, edema, shortness of breath).
Diagnosis: X-Ray and echocardiography, B-type natriuretic peptide levels indicating fluid overload and try to decrease blood volume and pressure.
Treatment of Heart Failure
Goals: Improve cardiac output, minimize congestive symptoms, decrease workload.
Strategies:
Preload Management: Diuretics and ACE inhibitors to reduce intravascular volume.
Afterload Management: Beta-blockers.
Contractility Management: Use of cardiac glycosides, digitalis, and possible use of pacemakers.
Dysrhythmias Overview
Definition: Abnormality in the cardiac rhythm affecting impulse generation or conduction.
Significance: Indicative of underlying pathophysiology and may impair normal cardiac output.
Mechanisms of Dysrhythmias
Types of Mechanisms:
Abnormal automaticity.
Triggered activity from depolarization.
Reentrant circuits.
Automaticity
Definition: Spontaneous generation of action potentials.
Causes: Failure to repolarize, sodium or calcium influx at rest.
Triggered Activity
Occurrence: Impulse generated during or just after repolarization due to membrane potential changes.
Reentry Mechanism
Impact: Associated with most tachydysrhythmias; occurs when the impulse continues to depolarize after the main impulse.
Predisposing Conditions: Myocardial ischemia or electrolyte abnormalities.
ECG Analysis
Function: Measures waveform amplitude, duration, and heart rate to evaluate dysrhythmias.
Types of Cardiac Dysrhythmias
Normal Sinus Rhythm
Characteristics: 60-100 beats/min, regular rhythm, normal PR and QRS intervals.
Sinus Tachycardia
Description: Fast heart rate (>100 beats/min); often compensatory.
Treatment: Correct underlying causes.
Sinus Bradycardia
Description: Slow heart rate (<60 beats/min); normal in some trained individuals.
Treatment: Address low cardiac output.
Atrial Dysrhythmias
Definition: Originate in the atria not involving the SA node, including premature atrial contractions.
Atrial Flutter and Fibrillation: Flutter shows rapid atrial rate; fibrillation is disorganized and irregular.
Ventricular Dysrhythmias
Types: Premature ventricular complexes and tachycardia (3+ complexes >100 beats/min).
Characteristics: Vital signs and CO may be compromised; may require quick intervention.
Conduction Disturbances
Types: Include delay, blocks, and abnormal pathways:
Atrioventricular Blocks:
First-degree: prolonged conduction through AV node (long PR interval).
Second-degree: Progressive prolonged PR intervals (Type I) or fixed number of P waves (Type II).
Third-degree: Complete block requiring pacemaker.
Accessory Pathways
Example: Wolff-Parkinson-White syndrome causing tachycardia from congenital extra conduction pathways.
Intraventricular Conduction Defects
Type: Bundle branch block affecting right and left ventricle conduction through conducting pathways.
Treatment of Dysrhythmias
Indication: For symptoms or progression risk; antiarrhythmic drugs utilized.
Interventions: Pacemakers, drugs to enhance contractility, and ablation procedures.